Begin main content

New at CADTH — January 2020

January 10, 2020
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

Patient Input and Clinical Experts: Vonvendi

January 2, 2020
CADTH has received the following notice(s) of pending drug submission(s). Brand name Vonvendi Generic name von Willebrand Factor [recombinant] Manufacturer Shire Pharma Canada ULC, now part of Takeda Indication(s) von Willebrand disease, adults (perioperative management) Project Number ...

Patient Input and Clinical Experts: Vonvendi

January 2, 2020
CADTH has received the following notice(s) of pending drug submission(s). Brand name Vonvendi Generic name von Willebrand Factor [recombinant] Manufacturer Shire Pharma Canada ULC, now part of Takeda Indication(s) von Willebrand disease, adults (treatment) Project Number ST0639-000 ...

Patient Input and Clinical Experts: Duobrii

December 19, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name Halobetasol propionate and tazarotene Generic name Duobrii Manufacturer Bausch Health, Canada Inc. Indication(s) Psoriasis, moderate to severe plaque Project Number SR0638-000 Call for patient...

New at CADTH — December 2019

December 9, 2019
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.